Late effects after allogeneic hematopoietic stem cell transplantation in patients with primary immunodeficiency
BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) has markedly improved survival in children with primary immunodeficiencies (PIDs) transforming previously fatal diseases into curable conditions. As survival improves late effects are …